# Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma

> **NCT06602986** · NA · NOT_YET_RECRUITING · sponsor: **Pak Emirates Military Hospital** · enrollment: 96 (estimated)

## Conditions studied

- HCC - Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** TACE

## Key facts

- **NCT ID:** NCT06602986
- **Lead sponsor:** Pak Emirates Military Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-12
- **Primary completion:** 2025-02-12
- **Final completion:** 2025-07-13
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06602986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06602986, "Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06602986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*